Higher 3Q profit, improved outlook for Johnson & Johnson
Johnson & Johnson’s third-quarter profit jumped 23%, beating Wall Street forecasts, thanks to higher sales of its key medicines for cancer and immune disorders and an acquisition-related charge a year earlier. The world’s biggest maker of health care products also raised its financial forecast for the year, and its shares jumped more than 2% in […]
Higher 3Q profit, improved outlook for Johnson & Johnson Read More »
